HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albiruni Abdul Razak Selected Research

Albiruni Abdul Razak Research Topics

Disease

3Neoplasms (Cancer)
01/2020 - 01/2019
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2024 - 12/2022
2Nausea
01/2023 - 01/2022
2Sarcoma (Soft Tissue Sarcoma)
01/2023 - 01/2022
1Disease Progression
01/2024
1Constipation
10/2023
1Hand-Foot Syndrome
01/2023
1Chondrosarcoma
01/2023
1Ewing Sarcoma (Sarcoma, Ewing)
01/2023
1Osteosarcoma (Osteogenic Sarcoma)
01/2023
1Vomiting
01/2023
1Mucositis
01/2023
1Rhabdomyosarcoma
11/2022
1Liposarcoma
01/2022
1Fatigue
01/2022

Drug/Important Bio-Agent (IBA)

3Sunitinib (Sutent)FDA Link
01/2024 - 12/2022
3ripretinibIBA
01/2024 - 12/2022
2Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2020
2Imatinib Mesylate (Gleevec)FDA Link
01/2024 - 12/2022
2Tyrosine Kinase InhibitorsIBA
01/2023 - 12/2022
2pembrolizumabIBA
01/2020 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2019
1cabozantinibIBA
01/2023
1regorafenibIBA
01/2023
1BilirubinIBA
01/2023
1selinexorIBA
01/2022
1Circulating Tumor DNAIBA
01/2020

Therapy/Procedure

1Drug Tapering
01/2023
1Aftercare (After-Treatment)
12/2022
1Radiotherapy
11/2022
1Immunotherapy
01/2019